andrea green grampians regional continence service · lower urinary tract dysfunction...

34
Andrea Green Grampians Regional Continence Service

Upload: others

Post on 19-Oct-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

  • Andrea Green

    Grampians Regional Continence Service

  • Embracing Technology!

    • Download app

    • or go to www.sli.do.com

    • Type in event code Enuresis and Join

    • Ask me questions Anonymously or Named

    • Questions answered at end of presentation

    • Switch to Polls to answer questions

    Enuresis

    http://www.sli.do.com/

  • Enuresis

  • Enuresis

    Symptom and condition of intermittent incontinence that occurs

    during sleep at the minimum age of 5 years

    Minimum of one wet night per month

    Minimum duration of three months

    Monosymptomatic: incontinence during sleep in the absence of

    lower urinary tract dysfunction

    Non-monosymptomatic: incontinence during sleep in combination

    with other bladder symptoms (urinary frequency, urge

    incontinence)

  • Enuresis; primary and secondary

    Primary; not yet achieving night dryness by the minimum age of 5

    years

    Secondary; enuresis after a period of 6 months dry at night. UTI,

    constipation or other specific cause

    Frequent; four nights or more per week

    Infrequent; less than four nights per week

    Austin et al. (2014) Rittig, S et al (2010)

  • Expected development - awareness

    Newborn – reflex voiding at intervals with no voluntary

    control

    Awareness of being wet around 18 months

    Awareness of urge around 2 years. Bladder volumes

    increase and voiding frequency decreases

    Ability to defer with urge around 3 years, able to inhibit

    and initiate voiding

    Ability to void on request (if urine in bladder) around 5

    years, good bladder storage and response to sensation

  • Mechanisms

  • Incidence of enuresis

    Second most common chronic condition in children aged

    6 – 7 years

    1 in 5 children of aged 5 - 7

    1 in 15 children aged 7 - 10

    1 in 20 children aged 10 - 15

    1 in 50 children aged 15

  • Potential causes of enuresis

    Hereditary

    Overactive bladder

    Poor arousal from the deep sleep phase

    Delay in antidiuretic hormone secretion

    Contributing factors such as faecal loading and bladderirritants

    Other factors – jaw alignment, sleep apnoea etc Weider, W.W., SateiaM.J., & West R.P. 1991

  • Expected bladder volumes

    30 ml per year of age, plus 30ml

    5 years - 180ml

    6 years - 210ml

    7 years - 240ml

    8 years - 250ml

    Older - adult volumes

    4 - 6 voids per day are expected

  • Estimating Fluid Requirements

    Age: Fluid / kg of body weight:

    3 months 125-150 ml

    6 months 140-160 ml

    6 months 130-155 ml

    12 months 120-135 ml

    2 years 15-125 ml

    6 years 90-100 ml

    10 years 70-85 ml

    14 years 50- 60 ml

    Depends which book you read… (look at the color of the urine)

    General rule of thumb: 30 – 40ml per kg of body weight

    Children 1000 - 1500ml per day

    Adult 1500 - 2000ml per day

    24ml/kg/day or 35 - 45ml/kg/day

    Mahan I.K.,& Arlin M. (1992). Krause’s Food, Nutrition and Diet Therapy. 8th Ed. WB Saunders Co. Philadelphia

  • Assessment

    Continence paediatric assessment tool. Look for red flags

    Bladder diaries +/-

    Uroflow +/-

    Urinalysis +/-

    Post void residual +/-

    Trigger diary for the intermittent wetters and regressors +/-

    Real time ultrasound – bowel, bladder wall thickness, PVR

    symptoms (urinary frequency, urge incontinence) +/-

  • General advice

    Push fluids early in the day

    Ensure adequate fluid input over all

    Urine color chart to guide fluid intake

    24ml per kg of body weight as a minimum guide

    If possible defer voiding a little, never go “just in case”,

    except before bed

    Good bowel habits

    Trigger diary may be required – bladder irritants

  • Alarm Therapy

    Alarm therapy has been considered first line

    management for the treatment of bedwetting in

    children. Alarms take longer to achieve dryness than

    Desmopressin but results are longer lasting. Glazener, MA, et al,

    Cochrane Systematic Review. 2005.

    Bell and pad style alarms are most commonly used in

    Australia

    Success rates estimated at 60-75% Butler & Glasson, 2005

    or at 76 – 87% Apos et.al., 2017

    The Grampians Regional Continence Service recently

    conducted a pilot study to compare the effectiveness

    of bell and pad with the body worn alarms – more on

    the study later…

    Apos et al, 2017. Butler & Glasson, 2005. Berry, 2006. Tsuji, et al, 2018

  • Urotherapy

    Alarm therapy

    Information provision

    Voiding habits

    Voiding posture

    Avoid holding manoeuvres

    Regular bowel habits

    Bladder and/or bowel diaries

    Support

  • Research Project – Pilot Study 2017

    GRCS conducted a Pilot Study comparing the bell and pad

    alarm with the body worn device

    Sample size was 86 children aged from 6 – 15 years

    There was a random allocation of alarm type to participants

    within the pilot study

    Success criteria was as per ICCS guidelines – 14 consecutive

    dry nights, maximum 16 weeks duration for therapy

  • Bell & Pad Body-Worn

    Cost ~$1,800 ~$130

    Therapy Success Rates ~60 - 85%

    Accessibility (Time to Therapy)

    Upwards of 6 months

    Immediate

    Clinician Involvement No Difference

    Research project – pilot study

  • Bell & Pad Body-Worn p Value

    Primary Measure(Dry ≥ 14 Nights)

    64% 44% 0.056

    Secondary Measure(Time to Dryness)

    44 nights 46 nights 0.818

    Other Measure (False Positive Alarms)

    20% 43% 0.039

    Other Measure (Alarm Woke Parent)

    88% 62% 0.022

    Other Measure (Child Turned Alarm Off –Back to sleep)

    6% 36% 0.003

    Results

  • Nocturnal polyuria

    Nocturnal polyuria - nocturnal urine production greater than

    130% of expected bladder capacity for age

    Normal bladder reservoir function, maximum voided volume

    greater than 70% of expected bladder capacity for age

    Greater than 20 X (age + 9) in ml

  • Pharmaceuticals – how do they relate

    to enuresis?

    Oxybutynin, Ditropan, Vesicare – Anticholenergics

    Betmiga – Beta antagonist

    Minirin / Desmopressin

    Hiprex, Vitamin C for prevention of urinary tract infection

    Jain S, Bhatt GC.Advances in the management of primary monosymptomatic nocturnal enuresis in children. Paediatric Int Child Health. 2015 May

    Bowel softeners - eg. OsmoLax / Movicol (iso-osmotic)

    Lactulose (osmotic)

    Bowel stimulants - eg. Dulcolax drops, Laxette chocolate

    squares, Senokot tablets

  • Minirin - Desmopressin

    Desmopressin is a synthetic replacement for the antidiuretic

    hormone that reduces urine production during sleep. Children

    taking Desmopressin are 4.5 times more likely to stay dry than

    those taking a placebo. Melt and tablet are prescribed, nasal

    spray is no longer recommended.

    Other children who are likely candidates for desmopressin

    treatment are those in whom alarm therapy has failed or those

    considered unlikely to comply with alarm therapy. It is useful

    for camps and sleepovers. Jain S, Bhatt GC. 2015 May

    Desmopressin only for treatment of nocturnal enuresis is

    associated with a high relapse rate. Thiedke CC, American Family Physician, 2003.

  • Anti-cholinergics - Ditropan, Vesicare

    Muscularinic receptor antagonists

    M3 selectivity - 3 fold selective

    M3 receptors - bladder (desired therapeutic effect)

    - salivary glands (dry mouth)

    - GI tract (constipation)

    Useful in non-monosymptomatic children with alarm

    therapy

    Not recommended as enuresis is a disorder of the central

    nervous system and not that of the bladder Yucal, Kol, Guntekin, Baykara, 2011

  • Betmiga – Mirabegron

    Beta-3 adrenoceptor agonist

    Useful in non-monosymptomatic children with alarm

    therapy

    Not recommended as enuresis is a disorder of the central

    nervous system and not that of the bladder

  • Hiprex – Methenamine

    Vitamin C – Ascorbic Acid

    Urinary tract infection management – preventative

    Hiprex turns to formaldehyde, makes urine acidic and kills

    bacteria

    Ceased while on antibiotics then recommenced

    Vitamin C can be prophylactic, converting nitrates to nitrites

    Nitrites convert to nitrogen oxides that are toxic to bacteria BannwartC, Hagmaier V, Straumann E, Hofer H, Vuillemier JP, Rutishauser G, 1981

  • Bowel softeners

    OsmoLax – Movicol – Macrogol 3350. Iso-osmotic

    Lactulose - Actilax. Osmotic

  • Bowel stimulants

    Senokot

    Dulcolax drops

    Laxette chocolate squares

  • Nocturnal Enuresis – adults

    Group Prevalence, %

    Age, years 16–20 21–25 26–30 31–35 36–40

    All enuretics 2.6  2.2  2.1  2.4  2.2

    male 3.3  2.2  2.2  2.5  2.8

    female 1.9  2.3  2.1  2.3  1.7

    Education Univ

    Enuretics 7.7 34.2 40.3 6.6  11.2

    Controls 3.7 16.1 46.8 10.7 22.7

    Sleep disturbance

    A B C D

    Enuretics 49.5 48.9 45.4 39.9

    Controls 33.1 27.4 33.8 25.8

    Prevalence of monosymptomatic PNE in adults in Hong

    Kong with age, education and sleep disturbance. Yeung C.K., Sihoe, F.D.Y., et al (2004)

  • Let’s talk about poo

    Bowel management may be required

    Faecal loading or constipation are space occupying in the

    pelvis

    Aim for a 5 minute toilet sit after the evening meal if bowels

    have not been opened yet for the day

    Teach toilet sitting position and pelvic floor relaxation

    techniques

    Manage stool type with softeners and stimulants as

    appropriate

  • Client Centred Care

    Is the child ready? Early treatment equates to better

    outcomes

    Are the parents ready?

    Two household families – parents living separately

    Compliance issues

    Other factors:

    Hot weather – sweating

    Wet weather – getting the linen dry

    Reflective listening

    Motivational interviewing techniques

    Establish goals and expectations

    Provide effective solutions

  • Cost factors

    Hire or purchase of alarms

    Medication costs

    Laundry costs

    Pull ups and continence products

    Time off work for appointments

    Economic cost to the taxpayer – service provision, funding

    schemes

  • Tom’s story

    Tom is a 10 year old boy who originally presented with

    monosymptomatic enuresis. There was no suggestion of any

    other problem.

    Tom had a failed alarm attempt and was lost to follow up for a

    short time.

    Tom re-attended the clinic for re-hire of bell and pad alarm for

    a second try.

    During the assessment it became clear that “something was

    not right” when a small comment was made by Tom’s mother

    (he had been wet during the day after a large void).

    A uroflow and post void residual led to the discovery of

    significant urinary retention. Alarm was not re-hired.

    The lesson: Ask the questions, don’t blindly re-hire.

  • Josie’s story

    Josie was 9 when we started to treat her enuresis.

    Josie initially came along with significant faecal loading, not at

    all toilet trained. Josie is deaf and has Down Syndrome.

    We elected to use the pad and bell style alarm with the

    vibrating disc attachment.

    Josie’s mother responded as expected to the bell. Josie never

    woke to the vibration of the disc but had her first dry night on

    night 9 with the alarm. Josie achieved 14 consecutive dry

    nights within 6 weeks and 5 days.

    Several years later, Josie has had some intermittent bowel

    problems but remains continent of urine both day and night.

  • Final thoughts…

    Be a game changer

    Sliding doors moments

    It might be routine work for us, but to the client the

    outcomes are important and life changing

  • References Apos, E., Schuster, S., Reece, J. Whitaker, S., Murphy, K., Golder, J., Leiper, B., Sullivan, L. & Gibb, S. (2017). Enuresis Management in Children: Retrospective Clinical Audit of 2861 Cases Treated with Practitioner-Assisted Bell-and-Pad Alarm, The Journal of Pediatrics, 193, 211-216.

    Austin, P.F., Bauer, S.B., Bower, W., Chase, J., Franco, I., Hoebeke, P., Rittig, S., Vande Walle, J., Von Gontard, A., Write, A., Yang, S.S. & Neveus, T. (2014). The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Update Report from the Standardization Committee of the International Children’s Continence Society.

    Bannwart C, Hagmaier V, Straumann E, Hofer H, Vuillemier JP, Rutishauser G. [Modifi cation of urinary pH through ascorbic acid]. Helv Chir Acta1981; 48 (3-4): 425-428.

    Berry, A.K. (2006) Helping Children with Nocturnal Enuresis: The wait-and-see approach may not be in anyone’s best interest, American Journal of Nursing, 106(8), 56-63.

    Caldwell, P.H.Y., Deshpande, A., & Von Gontard, A. (2013), Clinical Review: Management of nocturnal enuresis. British Medical Journal, 347, 1-6.

    Glazener, M.A., Evand J., Peto, R.E. (2005) Cochrane Systematic Review, 2005

    Jain S, Bhatt G.C. Advances in the management of primary monosymptomatic nocturnal enuresis in children. Paediatric Child Health. 2015 May

    Mahan I.K.,& Arlin M. (1992). Krause’s Food, Nutrition and Diet Therapy. 8th Ed. WB Saunders Co. Philadelphia

    Rittig, S., Kamperis, K., Siggaard, C. et al.: Age related nocturnal urine volume and maximum voided volume in healthy children: reappraisal of International Children’s Continence Society definitions. J Urol, 183: 1561, 2010

    Thiedke C.C, American Family Physician, April 2003

    Tsuji, S., Suruda, C., Kimata, T, Kino, J., Yamanouchi, S. & Kaneko, K. (2018) The Effect of Family Assistance to Wake Children with Monosymptomatic Enuresis in Alarm Therapy: A Pilot Study, The Journal of Urology, 199 (4), April, pp.1056-1060

    Weider D.J., Sateia M.J., West R.P. (1991) Nocturnal Enuresis in Children with Upper Airway Obstruction, 1991

    Yeung, C.K., Sihoe, J.D.Y., Sit, F.K.Y., Bower, W., Sreedhar, W., Lau, J. (2004) Characteristic of Primary Nocturnal enuresis in Adults: an epidemiological study BJUI International

    Yucal, S., Kol, A., Guntekin, E., & Baykara, M (2011). Anticholenergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis. Urology, 77, 721-724.